The Impact of Improved Vagal Function on Periaqueductal Gray Connectivity
1 other identifier
interventional
12
1 country
1
Brief Summary
This study is being to see if participating in breathing exercise training and practicing this training will help with Postural tachycardia syndrome (POTS). The information may help doctors to learn more about how the different parts of people's brains communicate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2022
CompletedFirst Posted
Study publicly available on registry
November 16, 2022
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
February 18, 2026
February 1, 2026
2.7 years
November 9, 2022
February 17, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Change in periaqueductal gray region (PAG) activation - looming task
Functional magnetic resonance imaging (fMRI) will be performed to measure activation of the PAG region during the looming task
90 minutes
Change in PAG activation - resting
Functional magnetic resonance imaging (fMRI) will be performed to measure activation of the PAG region while at rest
90 minutes
Change in Heart Rate Variability (HRV)
HRV will be measured using an ear clip and/or wristband and results will be recorded automatically in the app
Assessed for 2 days each week for the duration of the study (6 weeks).
Secondary Outcomes (10)
Change in Fatigue Severity Scale (FSS) score from baseline
Assessed at baseline, week 3, and week 6 (final visit).
Change in Generalized Anxiety Disorder Scale (GAD-2) score from baseline
Assessed at baseline, week 3, and week 6 (final visit).
Differences in Adverse Childhood Experiences (ACE) scores between participants
Assessed at baseline.
Change in Pain Catastrophizing Scale (PCS) score from baseline
Assessed at baseline, week 3, and week 6 (final visit).
Change in Patient Health Questionnaire (PHQ-9) score from baseline
Assessed at baseline, week 3, and week 6 (final visit).
- +5 more secondary outcomes
Study Arms (1)
Training
EXPERIMENTALInterventions
Participants will engage in weekly breathing exercises. They will be trained once a week for 4 weeks, and will use an app called Inner Balance and an device called Firstbeat Bodyguard 3 to track data about their hearts while practicing the exercises at home for 10 minutes a day, twice a day, once before bedtime.
Eligibility Criteria
You may qualify if:
- Age 18-50 years
- Diagnosis of POTS, orthostatic intolerance (with or without syncope), syncope, or near-syncope
- Can speak and read in English
- Upcoming new patient VCU Comprehensive Autonomics Center clinic visit scheduled at least 1 week in the future
You may not qualify if:
- Inflammatory arthritis, connective tissue or auto-immune disorder
- Any chronic neurological disorder besides POTS, orthostatic intolerance (with or without syncope), syncope, or near-syncope
- Patients who have already had a new patient clinic visit where they were exposed to breathing exercise education
- Evidence of unstable medical disorder, such as kidney (rising creatinine, or end-stage renal failure) or liver impairment (rising AST or ALT, or end-stage with coagulopathy), poorly controlled significant cardiovascular (CHF), respiratory, endocrine (diabetes - A1c \> 9 - or untreated thyroid dysfunction) or uncontrolled psychiatric illness (such as untreated depression, psychosis, etc.)
- Neuropathy, central nervous system disorder (e.g., Cerebral palsy, developmental delay, seizure disorder, MS, stroke, etc.)
- Treatment with a drug or medical device within the previous 30 days that has not received regulatory approval
- Use of hormones (except insulin, thyroid replacement or oral contraceptives, which will be carefully documented)
- Current substance or alcohol abuse
- Any major surgical intervention with general anesthesia in the last 60 days and minor procedure, such as tooth extraction, endoscopy, etc., with local or conscious sedation within 7 days
- Any on-going or pending medical, health or disability related litigation, or current pursuit of disability
- Any condition that in the judgment of the investigator would interfere with the patient's ability to provide informed consent, comply with study instructions, place the patient at increased risk, or which would clearly confound the interpretation of the study results (specific reason will be documented)
- Chronic use of narcotics for pain
- Claustrophobia or any metal hardware that may interfere with MRI
- Investigators and study staff
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virnigia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Chelimsky, M.D.
Virginia Commonwealth University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2022
First Posted
November 16, 2022
Study Start
April 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share